Thirty one initial public offerings have been priced so far this year as of Feb 9, 2006:

- 21 IPOs are currently trading above initial offering price;
- 9 are trading below the offering price;
- and 1 is trading at its offer price.

Fourteen IPOs were priced during the week of February 9th, 2007. There are three deals on deck for the next week hoping to raise nearly $675 million.

IPO PERFORMANCE

ADVANCERS:

Shares of Fortress Investment Group (FIG: chart) opened up 89% at $35 on its first day of trading Friday on the New York Stock Exchange.

On Thursday, the 34.3 million share offering sold for $18.50 each, at the high end of a $16.50 to $18.50 forecast range, raising $634 million.

The offering represents 8.5% stake in the company.

Goldman Sachs, Lehman Brothers, Banc of America, Citigroup, and Deutsche Bank managed the deal.

The underwriters have an option to purchase 5.1 million additional shares to cover over-allotments.

The stock closed at $31 a share its first day of trading, up as much as 68% from the IPO price.

Shares of Accuray Inc. (ARAY: chart) rose as much as 57% in their first day of trading Thursday. Shares of the company opened up 16.7% at $21 on the Nasdaq.

On Wednesday, the company raised $288 million by offering 16 million shares priced at $18 per share, at the high end of the $17 to $18 forecast range.

J.P. Morgan, UBS Investment Bank and Piper Jaffray were the lead underwriters.

The Sunnyvale, California-based company developed CyberKnife, a robotic radiosurgery machine designed to deliver high dosages of radiation directly to tumors.

The shares ended the week at $29.25, up 62.5% from the offering price.

Shares of U.S. Auto Parts Network Inc. (PRTS: chart) gained as much as 21% on their first day of trading Friday. Shares of the company opened up 10% at $11 on the Nasdaq.

The company raised $100 million with a 10 million share initial public offering priced at $10 a share, at the low end the $10 to $12 forecast range.

The company sold 8 million shares while selling stockholders offered the remaining 2 million shares.

RBC Capital Markets and Thomas Weisel Partners were the lead managers on the deal.

Underwriters have an option to buy 1.5 million additional shares to cover over-allotments.